![](/img/cover-not-exists.png)
Seven Years of Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope® in the Treatment of Growth Hormone Deficient Children: Results of a Phase III Study
Romer, T., Saenger, P., Peter, F., Walczak, M., Le Bouc, Y., Khan-Boluki, J., Berghout, A.Volume:
72
Year:
2009
Language:
english
Journal:
Hormone Research
DOI:
10.1159/000249164
File:
PDF, 345 KB
english, 2009